Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/19328
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | MacIsaac, Richard J | - |
dc.contributor.author | Ekinci, Elif I | - |
dc.date.accessioned | 2018-09-16T23:53:54Z | - |
dc.date.available | 2018-09-16T23:53:54Z | - |
dc.date.issued | 2017-12 | - |
dc.identifier.citation | Annals of Translational Medicine 2017; 5(23): 474 | en_US |
dc.identifier.issn | 2305-5839 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/19328 | - |
dc.language.iso | eng | - |
dc.title | Comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors: SGLT2 inhibitors in the real world. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Annals of Translational Medicine | en_US |
dc.identifier.affiliation | Medicine (University of Melbourne) | en_US |
dc.identifier.affiliation | Department of Endocrinology & Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia | en_US |
dc.identifier.affiliation | Department of Medicine, St Vincent's Hospital, University of Melbourne, Victoria, Australia | en_US |
dc.identifier.affiliation | Endocrinology | en_US |
dc.identifier.doi | 10.21037/atm.2017.10.11 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0003-2372-395X | en_US |
dc.identifier.pubmedid | 29285507 | - |
dc.type.austin | Editorial | - |
dc.type.austin | Comment | - |
local.name.researcher | Ekinci, Elif I | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Endocrinology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.